| Website | bioptix.com |
| Category | BioTech |
| Phone | 1-303-545-5550 |
| Employees | |
| Founded | 2003 |
| Description | Cancer Detection Technology |
| Total | $3.25M |
| Series A, 3/09 Boulder Ventures | $3M |
| Unattributed, 10/10 | $250k |
BiOptix Inc has developed a highly-sensitive biosensor for detection of trace amounts (~pg/mm2) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents in real-time and with minimal human intervention.
The prototype has been used by BiOptix scientists to detect clinically significant levels of human micro RNAs in experimental samples, opening an avenue for early and robust diagnostics of a variety of cancers.
After Dr. Misha Plam founded the company as AlphaSniffer in 2003, the company assumed the name of BiOptix in May of 2008.
